我国良性前列腺增生和前列腺癌发病调查

Epidemiological survey of benign prostatic hyperplasia and prostate cancer in China

目的:通过调查了解我国良性前列腺增生和前列腺癌发病现状。方法:调查全国30个省、市、自治区187所医院1997年泌尿外科住院病人中良性前列腺增生和前列腺癌所占的比例及北京医科大学泌尿外科研究所1951～1997年间住院病人中以上两病构成比变化。结果:全国187所医院1997年泌尿外科住院病人95749例,良性前列腺增生15459例(16.1%),前列腺癌1389例(1.5%)。所有医院都认为无论良性前列腺增生还是前列腺癌近年都有明显增长。北京医科大学泌尿外科研究所50年代良性前列腺增生和前列腺癌分别占住院病人7.6%和0.6%;90年代分别上升至18.5%和3.4%。结论:我国良性前列腺增生已成为泌尿外科最常见的疾病之一,前列腺癌的发生虽有增长仍远低于欧美国家。

Objective: To investigate the epidemiological survey of benign prostatic hyperplasia(BPH) and prostate cancer(CaP) in China in recent years.Methods: The urological hospital incidence of BPH and CaP in the year of 1997 in 30 districts of Chinese mainland was collected. The changing hospital incidence of BPH and CaP in Institute of Urology from 1951 to 1997 has been reviewed.Results: In 1997, 16.1%(15 459 of 95 749) and 1.5% (1 389 of 95 749) of the inpatients treated for urologic disorders among 187 hospitals in China were treated for BPH and CaP respectively. During the period from 1951 to 1960 urological inpatients in Institute of Urology,Beijing Medical University 7.6% and 0.6% were treated for BPH and CaP respectively. In the same hospital urological inpatients in the period from 1991 to 1997, 18.5% and 3.4% were treated for BPH and CaP respectively. Conclusion: The incidences of BPH and CaP are increasing rapidly in China. We can not draw the conclusion that prostate cancer is common in China.